Header Logo

Connection

JACOB MANDEL to Aged

Back to Details
This is a "connection" page, showing publications JACOB MANDEL has written about Aged.
JACOB MANDEL
Connection Strength
0.303
Aged
  1. Recurrent Papillary Glioneuronal Tumor. World Neurosurg. 2019 Aug; 128:127-130.
    View in: PubMed
    Score: 0.042
  2. Effect of health disparities on overall survival of patients with glioblastoma. J Neurooncol. 2019 Apr; 142(2):365-374.
    View in: PubMed
    Score: 0.041
  3. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. J Neurooncol. 2016 08; 129(1):147-54.
    View in: PubMed
    Score: 0.034
  4. Delayed imaging abnormalities of neuro-invasive West Nile virus in cancer patients. J Neurol Sci. 2015 Mar 15; 350(1-2):115-7.
    View in: PubMed
    Score: 0.031
  5. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol. 2014 Dec; 120(3):597-605.
    View in: PubMed
    Score: 0.030
  6. Lambrolizumab induced central nervous system (CNS) toxicity. J Neurol Sci. 2014 Sep 15; 344(1-2):229-31.
    View in: PubMed
    Score: 0.030
  7. Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated. Acta Neuropathol Commun. 2025 01 16; 13(1):9.
    View in: PubMed
    Score: 0.016
  8. Multicentric non-enhancing lesions in glioblastoma: A retrospective study. J Clin Neurosci. 2021 Mar; 85:20-26.
    View in: PubMed
    Score: 0.012
  9. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. J Geriatr Oncol. 2020 04; 11(3):451-454.
    View in: PubMed
    Score: 0.011
  10. Treatment strategies for glioblastoma in older patients: age is just a number. J Neurooncol. 2019 Nov; 145(2):357-364.
    View in: PubMed
    Score: 0.011
  11. Neurologic complications of immune checkpoint inhibitors. J Neurooncol. 2018 May; 137(3):601-609.
    View in: PubMed
    Score: 0.010
  12. Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. J Neurooncol. 2017 Oct; 135(1):75-81.
    View in: PubMed
    Score: 0.009
  13. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
    View in: PubMed
    Score: 0.008
  14. Wound healing complications in brain tumor patients on Bevacizumab. J Neurooncol. 2015 Sep; 124(3):501-6.
    View in: PubMed
    Score: 0.008
  15. Venous thromboembolism (VTE) and glioblastoma. J Neurooncol. 2015 Aug; 124(1):87-94.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.